Loan Capital Изменить Дата
AbbVie USD 55.63B 181M 2023-09
Acadia Pharmaceuticals USD 0 0 2022-06
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Amgen USD 63.17B 4.13B 2023-12
Arrowhead Research USD 263.06M 263.06M 2023-06
Biogen USD 6.79B 1.8M 2023-12
BioMarin Pharmaceutical USD 593.1M 509K 2023-12
Bluebird Bio USD 0 0 2022-06
Bristol-Myers Squibb USD 32.14B 2.52B 2023-09
Gilead Sciences USD 23.19B 1.98B 2023-09
Incyte USD 29.16M 303K 2023-12
Insmed USD 1.18B 7.11M 2023-12
Ionis Pharmaceuticals USD 1.23B 49.79M 2023-12
J&J USD 26.05B 7.85B 2023-09
Merck USD 33.97B 100M 2023-09
Moderna USD 575M 0 2023-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pfizer USD 61.05B 308M 2023-09
PTC Therapeutics USD 1.92B 673.35M 2023-12
Regeneron Pharmaceuticals USD 2.7B 300K 2023-12
Roche Holding CHF 20.35B 1.05B 2023-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06
United Therapeutics USD 300M 200M 2023-12
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



Vertex Pharmaceuticals Заемный Капитал - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2024.